Hypertension Clinical Trial
Official title:
Behaviorally Enhanced Messages to Increase Medical Check-ups
The study had two stages. Stage 1 involved an opportunistic screening for hypertension
conducted at the 2018 Beirut Marathon. During stage 1, participants whose measurements
indicated hypertension were invited to take part in a RCT (randomized controlled trial).
Stage 2 involved a RCT to evaluate the effectiveness of a behavioural intervention to
increase the proportion of participants who sought further medical attention. The research
team hypothesised that the intervention would increase the proportion of participants who
sought further medical attention compared to a control group that did not receive the
intervention.
This is a retrospective registration specifically focused on the RCT component of this study.
The study was conducted by Nudge Lebanon in partnership with B4- development (formerly known
as QBIU) and SmartScience. The RCT was not pre-registered because the collaborators were
unaware that pre-registration would be necessary. The collaborators asked the University of
Warwick to re-analyse and write the project up for publication after the study was complete.
The University of Warwick is now seeking to retrospectively register the trial before
submitting to an academic journal. The fact that this trial is retrospectively registered
will be plainly stated in the manuscript and all analyses will be presented as exploratory.
This study had two stages. Stage 1 involved an opportunistic screening and Stage 2 involved
in RCT. This registration focuses on the RCT but both stages are described here.
Stage 1. The opportunistic screening for hypertension was conducted around the 2018 Beirut
Marathon. Screening tents were set up at the marathon village during the four days leading up
to the marathon (7-10 November), where runners collected necessary materials for the run and
could take up the screening. An additional two tents were set up during the marathon day were
spectators could take part. Participants indicated their consent for the screening before
taking part. During their participation they completed surveys about their demographics and
health information (including whether they were hypertensive). After they completed the
survey, nurses and trained team members measured their blood pressure using calibrated
equipment. Those participants whose measurements indicated hypertension were invited to
participate in the RCT.
Stage 2. For the RCT participants were randomly assigned to either a intervention or control
group in a 1:1 fashion. Participants in the intervention group were sent a WhatsApp message
25 days after the marathon reminding them to seek help for their hypertensive condition.
Participants in the control group were not sent this message. Then one month later the
researchers called all these participants to ask wither they sought further medical
attention. The main outcome was whether participants self-reported seeking further medical
attention.
The research objectives were as follows:
Stage 1 screening: Evaluate if the opportunistic screening increased people's awareness of
their hypertensive condition.
Stage 2 RCT: Evaluate if the intervention increased the proportion of participants who sought
further medical attention.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |